CTIX is essentially flat to slightly up since Trum
Post# of 72440
I think, based purely on what seems to me to be slow enrollment data for a condition that affects 400,000 people a year in USA, that OM is the weaker of the ongoing trial candidates so that could be a factor in the stock currently being in the doldrums . Expect a large upside breakout if OM has even moderately good news.